Advances on the research of the pharmacological activity mechanism and toxicology of Glaucocalyxin A

CHI Qingqing; WANG Qiang; ZHONG Yanqiang

doi:10.3969/j.issn.1006-0111.2016.02.008

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Volume 34 Issue 2

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Practice and Service > 2016 > 34(2): 124-128

CHI Qingqing, WANG Qiang, ZHONG Yanqiang. Advances on the research of the pharmacological activity mechanism and toxicology of Glaucocalyxin A[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 124-128. doi: 10.3969/j.issn.1006-0111.2016.02.008

Citation:

CHI Qingqing, WANG Qiang, ZHONG Yanqiang. Advances on the research of the pharmacological activity mechanism and toxicology of Glaucocalyxin A[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 124-128. doi: 10.3969/j.issn.1006-0111.2016.02.008

Advances on the research of the pharmacological activity mechanism and toxicology of Glaucocalyxin A

doi: 10.3969/j.issn.1006-0111.2016.02.008

1.
Dalian Medical University, Dalian 116044, China
2.
No.202 Hospital of PLA, Shenyang 110003, China
3.
Second Military Medical University, Shanghai 200433, China

Received Date: 2015-10-28
Rev Recd Date: 2016-01-25

Abstract

Glaucocalyxin A(GLA) is a kind of diterpenoid enantiomers with organic chemical structure of en-15-oxo-16-kaurene. It has various pharmacological activities, such as cardiovascular and endothelium cellular protection, anti-blood coagulation, anti-Hepatitis B Virus(HBV), anti-tumor, anti-bacteria, anti-inflammation, hypoxic tolerance, immunomodulation and Ca²⁺ concentration regulation effect, where as its in vivo safety is quite good. As a folk medicine, it is conventionally used to treat hepatitis, gastritis, mastitis, stomachache and arthralgia. It is also used for ischemic and/or hypoxic cardio-cerebrovascular diseases such as coronary heart diseases, stenocardia and chronic cerebral circulation insufficiency in clinic. This review gives a summary of the pharmacological effects, biological mechanism, and toxicity of Glaucocalyxin A.
- Glaucocalyxin A,
- Rabdosia(BI.) Hassk,
- pharmacological activity,
- toxicology

References

[1]	余祖胤.对映贝壳杉烷类二萜化合物抗肿瘤作用及其分子机制研究[D]. 中国人民解放军军事医学科学院,2007.
[2]	张冰月,郎轶咏,王强.蓝萼甲素抗血小板聚集的研究[J].中医药信息,2014,31(6):23-26.
[3]	张雯,宋俊科,杜冠华.缺血再灌注损伤与细胞凋亡信号转导通路[J].中国药学杂志, 2015,50(7):565-569.
[4]	Duan X, Ji BY, Wang XH, et al. Expression of microRNA-1 and microRNA-21 in different protocols of ischemic conditioning in an isolatedrat heart model[J]. Cardiology,2012,122(1):36-43.
[5]	Kang S, Yang YJ, Wu YL, et al. Myocardium and microvessel endothelium, apoptosis at day 7 following reperfused acute myocardial infarction[J]. Microvasc Res, 2010, 79(1):70-79.
[6]	刘明洁,孙旗,王强,等.蓝萼香茶菜总二萜预处理对兔心肌缺血/再灌注时心肌细胞凋亡的影响[J].中国实验方剂学杂志,2013,19(19):229-233.
[7]	李上海,梁伟钧,孙炎华,等.缺血预处理对心肌缺血再灌注诱发凋亡的保护机制[J].国际心血管病杂志,2014,41(1):48-50.
[8]	刘兰娣,叶丽卡,潘东军,等.蓝萼香茶菜对大鼠全心缺血-再灌注时心肌C-fos基因表达的影响[J].中国中药杂志,2003,28(4):358-361.
[9]	谷洁,隋海静,李冬梅,等.内皮素与一氧化氮在2型糖尿病大鼠心肌缺血再灌注损伤中的变化及意义[J].国际免疫学杂志, 2013,36(3):235-238.
[10]	夏龙,褚纯隽,严彪,等.蓝萼甲素对血管内皮细胞的保护作用[J].中医药导报,2014,20(4):22-24.
[11]	海广范,张慧,郭兰青.二萜类化合物药理学作用研究进展[J].新乡医学院学报,2015,32(1):77-80.
[12]	王保强,丁兰,达文燕,等.蓝萼香茶菜叶与茎乙醇提取物的抑菌活性研究[J].安徽农业科学,2010,38(31):17526-17528.
[13]	马占强,王敏,张健,等.蓝萼甲素抗凝血作用研究[J].云南中医学院学报,2011,34(3):26-29.
[14]	朱晓红,张冰月,王莹莹,等.蓝萼香茶菜总二萜对小鼠抗凝血作用[J].中国公共卫生2013,29(1):86-87.
[15]	汤晓蓉.蓝萼甲素对缺氧缺血性脑损伤保护作用的研究[D].苏州大学,2013.
[16]	HasegawaY,Suzuki H,Sozen T,et al.Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats[J].Stroke,2010,41(2):368-374.
[17]	Zhou Y, Lekic T, Fathali N,et al. Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway[J].Stroke, 2010. 41(7):1521-1527.
[18]	刘洪川,项昭保,金永生,等.蓝萼香茶菜化学成分与结构修饰及抗肿瘤和抗乙肝病毒作用研究[C].2013中国药学大会暨第十三届中国药师周论文集,2014.
[19]	王伟超. 核仁蛋白EBP2反馈调控转录因子c-Myc影响rDNA转录、细胞增殖以及肿瘤形成[D].华东师范大学,2015.
[20]	应娜,徐长亮,张健,等.蓝萼甲素对入肝癌细胞HepG2细胞株的作用[J].海峡药学,2012,24(1):235-238.
[21]	李梦姣,顾振纶,董丽霞,等.蓝萼甲素对人肺癌A549细胞的作用及其机制[J].中国药理学通报,2013,29(6):882.
[22]	Gao LW, Zhang J, Yang WH. Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells through mitochondria-mediated death pathway[J].Toxicol in vitro, 2011,25(1):51-63.
[23]	刘学忠,薛彬,袁燕,等.乐果引起大鼠肝细胞凋亡的机理[J].中国兽医学报,2010,30(1):98-101.
[24]	Xiong XX, Liu JM, Qiu XY, et al. Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways[J]. Acta Pharmacol Sin, 2015, 36(3):362-374.
[25]	杨文华,张健,高立文,等.蓝萼甲素诱导K562细胞毒作用机制的初步研究[J].中国实验方剂学杂志,2011,17(19):181-184.
[26]	黄敬敬,王修珍,蒋小岗,等.蓝萼甲素对宫颈HeLa细胞的作用及其相关机制研究[J].中国药理学通报,2012,28(3):421-424.
[27]	夏维,王修珍,蒋小岗,等.蓝萼甲素对人宫颈鳞癌SiHa细胞株生长抑制作用[J].中国药理学通报,2011,27(7):1035-1036.
[28]	陈子珺,李云森,周吉燕,等.蓝萼甲素对小鼠脾细胞Th1/Th2型5种细胞因子水平的影响[J].中国中药杂志,2006,31(15):1257-1260.
[29]	陈子珺,李云森,周吉燕,等.蓝萼甲素对小鼠脾细胞内游离钙离子浓度的影响[J].中草药,2006,37(6):908-910.
[30]	崔婷婷,赵丽娟,刘岩,等.蓝萼香茶菜的毒理学研究[J].中国医药指南,2010,08(19):246-249.
[31]	沈晓丹,曹莉,董霞,等.蓝萼甲素体外细胞毒活性研究[J].中华中医药学刊,2011,29(6):1334-1335.

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views(3359) PDF downloads(27) Cited by()

Proportional views

Advances on the research of the pharmacological activity mechanism and toxicology of Glaucocalyxin A

1. Dalian Medical University, Dalian 116044, China

2. No.202 Hospital of PLA, Shenyang 110003, China

3. Second Military Medical University, Shanghai 200433, China

Received Date: 2015-10-28

Rev Recd Date: 2016-01-25

Key words:

Abstract: Glaucocalyxin A(GLA) is a kind of diterpenoid enantiomers with organic chemical structure of en-15-oxo-16-kaurene. It has various pharmacological activities, such as cardiovascular and endothelium cellular protection, anti-blood coagulation, anti-Hepatitis B Virus(HBV), anti-tumor, anti-bacteria, anti-inflammation, hypoxic tolerance, immunomodulation and Ca²⁺ concentration regulation effect, where as its in vivo safety is quite good. As a folk medicine, it is conventionally used to treat hepatitis, gastritis, mastitis, stomachache and arthralgia. It is also used for ischemic and/or hypoxic cardio-cerebrovascular diseases such as coronary heart diseases, stenocardia and chronic cerebral circulation insufficiency in clinic. This review gives a summary of the pharmacological effects, biological mechanism, and toxicity of Glaucocalyxin A.

HTML

Reference (31)

[1]	余祖胤.对映贝壳杉烷类二萜化合物抗肿瘤作用及其分子机制研究[D]. 中国人民解放军军事医学科学院,2007.
[2]	张冰月,郎轶咏,王强.蓝萼甲素抗血小板聚集的研究[J].中医药信息,2014,31(6):23-26.
[3]	张雯,宋俊科,杜冠华.缺血再灌注损伤与细胞凋亡信号转导通路[J].中国药学杂志, 2015,50(7):565-569.
[4]	Duan X, Ji BY, Wang XH, et al. Expression of microRNA-1 and microRNA-21 in different protocols of ischemic conditioning in an isolatedrat heart model[J]. Cardiology,2012,122(1):36-43.
[5]	Kang S, Yang YJ, Wu YL, et al. Myocardium and microvessel endothelium, apoptosis at day 7 following reperfused acute myocardial infarction[J]. Microvasc Res, 2010, 79(1):70-79.
[6]	刘明洁,孙旗,王强,等.蓝萼香茶菜总二萜预处理对兔心肌缺血/再灌注时心肌细胞凋亡的影响[J].中国实验方剂学杂志,2013,19(19):229-233.
[7]	李上海,梁伟钧,孙炎华,等.缺血预处理对心肌缺血再灌注诱发凋亡的保护机制[J].国际心血管病杂志,2014,41(1):48-50.
[8]	刘兰娣,叶丽卡,潘东军,等.蓝萼香茶菜对大鼠全心缺血-再灌注时心肌C-fos基因表达的影响[J].中国中药杂志,2003,28(4):358-361.
[9]	谷洁,隋海静,李冬梅,等.内皮素与一氧化氮在2型糖尿病大鼠心肌缺血再灌注损伤中的变化及意义[J].国际免疫学杂志, 2013,36(3):235-238.
[10]	夏龙,褚纯隽,严彪,等.蓝萼甲素对血管内皮细胞的保护作用[J].中医药导报,2014,20(4):22-24.
[11]	海广范,张慧,郭兰青.二萜类化合物药理学作用研究进展[J].新乡医学院学报,2015,32(1):77-80.
[12]	王保强,丁兰,达文燕,等.蓝萼香茶菜叶与茎乙醇提取物的抑菌活性研究[J].安徽农业科学,2010,38(31):17526-17528.
[13]	马占强,王敏,张健,等.蓝萼甲素抗凝血作用研究[J].云南中医学院学报,2011,34(3):26-29.
[14]	朱晓红,张冰月,王莹莹,等.蓝萼香茶菜总二萜对小鼠抗凝血作用[J].中国公共卫生2013,29(1):86-87.
[15]	汤晓蓉.蓝萼甲素对缺氧缺血性脑损伤保护作用的研究[D].苏州大学,2013.
[16]	HasegawaY,Suzuki H,Sozen T,et al.Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats[J].Stroke,2010,41(2):368-374.
[17]	Zhou Y, Lekic T, Fathali N,et al. Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway[J].Stroke, 2010. 41(7):1521-1527.
[18]	刘洪川,项昭保,金永生,等.蓝萼香茶菜化学成分与结构修饰及抗肿瘤和抗乙肝病毒作用研究[C].2013中国药学大会暨第十三届中国药师周论文集,2014.
[19]	王伟超. 核仁蛋白EBP2反馈调控转录因子c-Myc影响rDNA转录、细胞增殖以及肿瘤形成[D].华东师范大学,2015.
[20]	应娜,徐长亮,张健,等.蓝萼甲素对入肝癌细胞HepG2细胞株的作用[J].海峡药学,2012,24(1):235-238.
[21]	李梦姣,顾振纶,董丽霞,等.蓝萼甲素对人肺癌A549细胞的作用及其机制[J].中国药理学通报,2013,29(6):882.
[22]	Gao LW, Zhang J, Yang WH. Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells through mitochondria-mediated death pathway[J].Toxicol in vitro, 2011,25(1):51-63.
[23]	刘学忠,薛彬,袁燕,等.乐果引起大鼠肝细胞凋亡的机理[J].中国兽医学报,2010,30(1):98-101.
[24]	Xiong XX, Liu JM, Qiu XY, et al. Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways[J]. Acta Pharmacol Sin, 2015, 36(3):362-374.
[25]	杨文华,张健,高立文,等.蓝萼甲素诱导K562细胞毒作用机制的初步研究[J].中国实验方剂学杂志,2011,17(19):181-184.
[26]	黄敬敬,王修珍,蒋小岗,等.蓝萼甲素对宫颈HeLa细胞的作用及其相关机制研究[J].中国药理学通报,2012,28(3):421-424.
[27]	夏维,王修珍,蒋小岗,等.蓝萼甲素对人宫颈鳞癌SiHa细胞株生长抑制作用[J].中国药理学通报,2011,27(7):1035-1036.
[28]	陈子珺,李云森,周吉燕,等.蓝萼甲素对小鼠脾细胞Th1/Th2型5种细胞因子水平的影响[J].中国中药杂志,2006,31(15):1257-1260.
[29]	陈子珺,李云森,周吉燕,等.蓝萼甲素对小鼠脾细胞内游离钙离子浓度的影响[J].中草药,2006,37(6):908-910.
[30]	崔婷婷,赵丽娟,刘岩,等.蓝萼香茶菜的毒理学研究[J].中国医药指南,2010,08(19):246-249.
[31]	沈晓丹,曹莉,董霞,等.蓝萼甲素体外细胞毒活性研究[J].中华中医药学刊,2011,29(6):1334-1335.

Message Board

Advances on the research of the pharmacological activity mechanism and toxicology of Glaucocalyxin A

doi: 10.3969/j.issn.1006-0111.2016.02.008

Abstract

References

Proportional views

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Related

Proportional views